These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18227088)

  • 1. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
    Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
    J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
    Novak RM; Chen L; MacArthur RD; Baxter JD; Huppler Hullsiek K; Peng G; Xiang Y; Henely C; Schmetter B; Uy J; van den Berg-Wolf M; Kozal M;
    Clin Infect Dis; 2005 Feb; 40(3):468-74. PubMed ID: 15668873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
    Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan.
    Lan YC; Elbeik T; Dileanis J; Ng V; Chen YJ; Leu HS; Cheng SH; Wong JC; Wong WW; Chen YM
    J Med Virol; 2008 Feb; 80(2):183-91. PubMed ID: 18098141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients.
    Metzner KJ; Allers K; Rauch P; Harrer T
    AIDS; 2007 Mar; 21(6):703-11. PubMed ID: 17413691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy.
    Ormaasen V; Sandvik L; Asjø B; Holberg-Petersen M; Gaarder PI; Bruun JN
    HIV Med; 2004 Nov; 5(6):400-6. PubMed ID: 15544691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.
    Fox J; Dustan S; McClure M; Weber J; Fidler S
    HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome.
    Jakobsen MR; Tolstrup M; Søgaard OS; Jørgensen LB; Gorry PR; Laursen A; Ostergaard L
    Clin Infect Dis; 2010 Feb; 50(4):566-73. PubMed ID: 20085464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.
    von Wyl V; Yerly S; Bürgisser P; Klimkait T; Battegay M; Bernasconi E; Cavassini M; Furrer H; Hirschel B; Vernazza PL; Francioli P; Bonhoeffer S; Ledergerber B; Günthard HF;
    Clin Infect Dis; 2009 Apr; 48(7):979-87. PubMed ID: 19228107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
    Delaugerre C; Morand-Joubert L; Chaix ML; Picard O; Marcelin AG; Schneider V; Krivine A; Compagnucci A; Katlama C; Girard PM; Calvez V
    Antivir Ther; 2004 Jun; 9(3):415-21. PubMed ID: 15259904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
    Sá-Ferreira JA; Brindeiro PA; Chequer-Fernandez S; Tanuri A; Morgado MG
    Transfusion; 2007 Jan; 47(1):97-102. PubMed ID: 17207236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
    de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
    J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral-drug resistance among patients recently infected with HIV.
    Little SJ; Holte S; Routy JP; Daar ES; Markowitz M; Collier AC; Koup RA; Mellors JW; Connick E; Conway B; Kilby M; Wang L; Whitcomb JM; Hellmann NS; Richman DD
    N Engl J Med; 2002 Aug; 347(6):385-94. PubMed ID: 12167680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan.
    Lin YT; Lan YC; Chen YJ; Huang YH; Lee CM; Liu TT; Wong WW; Yang JY; Wang CT; Chen YM
    J Infect Dis; 2007 May; 195(9):1283-93. PubMed ID: 17396997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
    Zhang X; Li S; Li X; Li X; Xu J; Li D; Ruan Y; Xing H; Zhang X; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S59-65. PubMed ID: 18172393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.